Colon AiQ
Early Cancer Detection with Colon AiQ test for colorectal cancer
Colon AiQ provides an alternative screening option for individuals who delay undergoing a colonoscopy. Using advanced molecular biology, it helps detect whether there’s an urgent need for a colonoscopy
The test also serves as a mid-level screening solution for those with diagnosed colon syndroms or a genetic predisposition to cancer, who need regular check-ups due to their increased risk of developing colorectal cancer.
Who should test with Colon AiQ ?
People over the age of 45 should take part in regular screening for colorectal cancer according to International Guidelines
Yet, many people tend to postpone colonoscopy, often because it’s an invasive procedure. The Colon AiQ test is a perfect solution to help us stay on top of our preventive colon health checks, giving us a clear understanding of our well-being and safety.
Colon AiQ is the most accurate non-invasive test for colorectal cancer screening available in Europe and now introduced to the UAE, combining advanced molecular biology with state-of-the-art Artificial Intelligence technology.
Why Colon AiQ could be the right test for you
High accuracy
Colon AiQ is considered the most precise non-invasive screening test available, with outstanding performance in detecting positive cases. Its sensitivity rate of 86% and specificity of 92% make it far more reliable than traditional stool-based tests (FIT) and cancer marker blood tests, especially for catching colorectal cancer in its early or even precancerous stages. In fact, it offers 57% greater sensitivity than stool self-tests for early detection.
Unique ability to identify adenomas and polyps
Colon AiQ goes beyond what most tests offer. It is currently the only molecular test capable of detecting both polyps and adenomas, early indicators that could lead to colorectal cancer if not addressed. Identifying these lesions early supports timely medical intervention and enables gastroenterologists to tailor follow-up schedules for effective prevention.
Simple, stress-free process with no preparation needed
Taking the test is quick and convenient. All it requires is a standard blood sample, no fasting, no special prep You can conveniently book an appointment to have your blood sample collected at your preferred location, and once your prepaid sample is sent to the lab, results are available within 12 working days. It’s a seamless experience from start to finish.
Proven Accuracy Through Clinical Studies
Colon AiQ’s performance has been proven through large-scale clinical research. A major study presented at ESMO 2024, involving more than 200,000 participants, confirmed the test’s ability to identify asymptomatic individuals with early-stage colorectal abnormalities, allowing for early, potentially life-saving treatment through minimally invasive procedures.
In addition, two separate studies involving 595 and 300 participants further support the test’s ability to detect even the earliest signs of cancer. These studies: Multilocus Blood-Based Colon Cancer Screening and MRD, underscore its reliability.
Scientifically validated by trusted experts
Colon AiQ has been thoroughly reviewed and verified by a dedicated scientific team. Their research confirms the test’s strong diagnostic performance and its value in modern preventive healthcare.
Colon AiQ vs. self test (FIT)
Colon AiQ | Self-Test (FIT) |
A cutting-edge molecular blood test that examines specific DNA methylation markers, processed in certified laboratories by skilled molecular biologists | A basic test that checks for hidden blood in stool samples. |
Identifies adenomas and polyps regardless of whether they cause bleeding | Only detects polyps or adenomas if they bleed, which may not occur in early stages |
Offers strong accuracy in detecting cancer at stages I & II. | Lower sensitivity for early-stage cancer, making early detection more difficult |
Understanding the Colon AiQ Testing Process
Colon AiQ is a non-invasive blood test, also known as a liquid biopsy. It works by analyzing the methylation patterns of five specific genetic regions found in cell-free DNA (cfDNA) circulating in your blood.
When colon cancer or precancerous lesions like advanced adenomas are present, the methylation in these regions changes. By detecting these early alterations, Colon AiQ can spot warning signs of cancer long before symptoms appear, making it possible to act early with a follow-up colonoscopy and prevent the disease from progressing.
Understanding Your Colon AiQ Results
Negative Signal Detected
A negative result means no signs of concern were found at the time of testing. While this is reassuring, it’s still important to stay proactive, meaning repeat the test annually and continue regular screening to protect your colon health.
Positive Signal Detected
A positive result indicates a higher risk of colorectal cancer. In this case, it’s important to follow up promptly with a gastroenterologist for further evaluation and diagnostic procedures.
Frequently Asked Questions
Why should I consider taking the Colon AiQ screening test for colorectal cancer
Colorectal cancer ranks as the third most common cancer globally—after breast and lung—and is the second leading cause of cancer-related deaths. The good news is that early detection (stages I & II) results in successful treatment for up to 90% of patients.
Colon AiQ offers a practical solution for individuals who are reluctant to undergo a colonoscopy. It provides an in-depth, non-invasive molecular screening. It’s also ideal for high-risk individuals as a supplemental check between colonoscopies, reducing the need for repeated invasive procedures.
Can Colon AiQ identify polyps that may become cancerous?
Yes. Colon AiQ is designed to detect adenomatous polyps, growths in the colon lining that may develop into cancer over time if left untreated.
How is Colon AiQ different from stool-based self-tests like FIT?
The differences between Colon AiQ and traditional stool tests (such as FIT) are significant:
- Colon AiQ analyzes genetic material (cfDNA) in the blood, using advanced molecular biology and epigenetic markers to detect early signs of colorectal cancer. It has higher sensitivity than FIT self-tests, especially when it comes to identifying early-stage cancers and precancerous lesions like polyps that may not yet cause symptoms.
- The FIT test detects traces of hidden blood in the stool, which can be a sign of colorectal cancer. However, it may miss cancers or polyps that aren’t bleeding, and false positives can occur due to unrelated bleeding causes. It is generally more effective at detecting later-stage disease.
How can I order the Colon AiQ test?
Do I need a referral from a doctor?
it’s always advisable to speak with your doctor, especially if your results are positive.
What kind of sample is needed?
A 10ml blood sample is required for the Colon AiQ test.
Is there anything I need to do to prepare?
No, special preparation is needed before taking the test.
How long does it take to get the results?
You’ll receive your results within 12 working days from the time your sample arrives at our company.
How will I get my results?
Results will be available on your personal doctor and to you
Is Colon AiQ approved and trustworthy?
Yes. Colon AiQ is in active use across Europe and beyond, with over 250,000 tests conducted since its launch in 2022. It holds the CE IVD certification, complying with EU standards for diagnostic tests (Directive 98/79/EC).
Colon AiQ offers a safe, certified, and non-invasive method for early detection of colorectal cancer.
Who should I contact if I have further questions?
Please contact our Customer Service Team at +971 4 578 7232
